Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
Trial details
- Registry ID
- NCT05466890
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Active study medication
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)NCT05466890 | PTN | Phase 2 | Active not recruiting | 2025-02-10Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |